LIBERATORE, Carmine
 Distribuzione geografica
Continente #
NA - Nord America 564
AS - Asia 541
EU - Europa 282
SA - Sud America 91
AF - Africa 13
OC - Oceania 1
Totale 1.492
Nazione #
US - Stati Uniti d'America 532
SG - Singapore 216
CN - Cina 125
IT - Italia 120
VN - Vietnam 75
BR - Brasile 72
RU - Federazione Russa 55
BD - Bangladesh 48
HK - Hong Kong 23
FI - Finlandia 18
DE - Germania 17
CA - Canada 13
GB - Regno Unito 13
AT - Austria 12
MX - Messico 12
IN - India 11
NL - Olanda 9
PL - Polonia 9
FR - Francia 7
TR - Turchia 7
AR - Argentina 6
JP - Giappone 6
LT - Lituania 5
PK - Pakistan 5
SA - Arabia Saudita 5
ZA - Sudafrica 5
BE - Belgio 4
EC - Ecuador 4
ES - Italia 4
UZ - Uzbekistan 4
KR - Corea 3
SE - Svezia 3
VE - Venezuela 3
CL - Cile 2
CO - Colombia 2
CR - Costa Rica 2
ID - Indonesia 2
MY - Malesia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BO - Bolivia 1
BW - Botswana 1
CM - Camerun 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GD - Grenada 1
GR - Grecia 1
HN - Honduras 1
IE - Irlanda 1
IQ - Iraq 1
IR - Iran 1
JM - Giamaica 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 1.492
Città #
Singapore 161
San Jose 123
Dallas 78
Ashburn 58
Council Bluffs 37
Los Angeles 30
Pescara 30
Ho Chi Minh City 26
Beijing 25
Hong Kong 23
Hanoi 19
New York 15
Orem 13
Milan 12
Santa Clara 12
São Paulo 11
Lappeenranta 10
Shenzhen 10
Buffalo 9
Hefei 9
Helsinki 8
Nuremberg 8
The Dalles 8
Tongling 8
Mexico City 7
Warsaw 7
Chennai 6
Redondo Beach 6
Rome 6
Manchester 5
Moscow 5
Vienna 5
Ankara 4
Atlanta 4
Chicago 4
Denver 4
Frankfurt am Main 4
Haiphong 4
Houston 4
Lauterbourg 4
Montreal 4
Seattle 4
Tokyo 4
Amsterdam 3
Brooklyn 3
Da Nang 3
Florence 3
Francavilla al Mare 3
Hải Dương 3
Jeddah 3
Johannesburg 3
London 3
Mumbai 3
Phoenix 3
Querétaro 3
Quito 3
San Francisco 3
Seoul 3
Tashkent 3
Bari 2
Belo Horizonte 2
Boston 2
Buenos Aires 2
Caracas 2
Caxias do Sul 2
Cepagatti 2
Charlotte 2
Curitiba 2
Ghent 2
Hove 2
João Pessoa 2
Lahore 2
Massa Lombarda 2
Oklahoma City 2
Padua 2
Poplar 2
Porto Alegre 2
Ribeirão Preto 2
Rio de Janeiro 2
Riyadh 2
San José 2
Stockholm 2
Turin 2
Vila Velha 2
Viçosa 2
Xi'an 2
Antofagasta 1
Aquiraz 1
Areado 1
Ascoli Piceno 1
Auckland 1
Baku 1
Barrancabermeja 1
Bauru 1
Belgrade 1
Betim 1
Bologna 1
Brasília 1
Buon Ma Thuot 1
Bắc Giang 1
Totale 950
Nome #
Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation 133
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia 112
Overview of 1q abnormalities in multiple myeloma: scientific opinions from Italian experts 109
Long-Term Survival with Multiple Myeloma: An Italian Experience 109
Allogeneic stem cell transplantation in multiple myeloma: is there still a place? 94
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors 86
Novel Approaches to Treatment of Acute Myeloid Leukemia Relapse Post Allogeneic Stem Cell Transplantation 81
Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB 76
Comparison of isatuximab-pomalidomide-dexamethasone versus elotuzumab-pomalidomidedexamethasone in relapsed/refractory multiple myeloma patients: a target trial emulation using real-world data 75
Immune Reconstitution-Based Score for Risk Stratification of Chronic Graft-Versus-Host Disease Patients 75
Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study 74
Cytomegalovirus infection after autologous transplantation in patients with multiple myeloma exposed to daratumumab 71
Breakthrough Invasive Fungal Infections in Allogeneic Hematopoietic Stem Cell Transplantation 68
Higher cyclophosphamide dose grants optimal stem-cell collection after daratumumab-based induction in multiple myeloma 68
Daratumumab‐based induction and autologous transplantation in concomitant multiple myeloma and chronic myeloid leukemia 62
Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials 51
Use of defibrotide in COVID-19 pneumonia: comparison of a phase II study and a matched real-world cohort control 45
Infection events in patients with newly diagnosed multiple myeloma with anti-CD38 monoclonal antibody-based first line regimens: A multicentric Italian experience 39
The Strange Case of Functional High-Risk Multiple Myeloma Patients: Is It Possible to Identify Them in Clinical Practice? 37
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 36
Continous or fixedcarfilzomib, lenalidomide and dexamethasone (krd) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life surveyfrom European myeloma network (emn) Italy 33
Cytogenetic Features and Their Implications in Clinical Practice: A Real-World Analysis of a Large Cohort of Multiple Myeloma Patients 22
A nationwide Italian GIMEMA survey on tandem autologous stem cell transplantation for newly diagnosed multiple myeloma patients treated with daratumumab, bortezomib, thalidomide and dexamethasone 9
Pomalidomide, bortezomib and dexamethasone in multiple myeloma refractory to lenalidomide and anti-CD38 monoclonal antibodies: outcomes from a real-world experience 5
Imaging in Plasma-Cell Neoplasms: Italian Experts' Recommendations 5
REALiTEC: a multi-country observational retrospective study of teclistamab in patients with relapsed/refractory multiple myeloma outside of clinical trials 4
Undetectable Minimal Residual Disease in Multiple Myeloma: Bridging the Gap Between Clinical Trials and Real-life Application 1
Recurrent cytokine release syndrome in patients receiving bispecific antibody therapy for multiple myeloma: a case series 1
Totale 1.581
Categoria #
all - tutte 5.096
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.096


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202429 1 0 0 3 0 0 6 7 7 1 1 3
2024/2025334 8 23 20 9 20 50 42 22 30 24 28 58
2025/20261.218 53 48 123 157 118 58 165 87 113 115 119 62
Totale 1.581